Gensight Biologics Sa Stock Fundamentals
| GSGTF Stock | USD 0.45 0.00 0.00% |
GenSight Biologics SA fundamentals help investors to digest information that contributes to GenSight Biologics' financial success or failures. It also enables traders to predict the movement of GenSight Pink Sheet. The fundamental analysis module provides a way to measure GenSight Biologics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GenSight Biologics pink sheet.
GenSight |
GenSight Biologics SA Company Operating Margin Analysis
GenSight Biologics' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current GenSight Biologics Operating Margin | (6.59) % |
Most of GenSight Biologics' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GenSight Biologics SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, GenSight Biologics SA has an Operating Margin of -6.5859%. This is 81.23% lower than that of the Healthcare sector and 94.12% lower than that of the Biotechnology industry. The operating margin for all United States stocks is 19.53% higher than that of the company.
GenSight Biologics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GenSight Biologics's current stock value. Our valuation model uses many indicators to compare GenSight Biologics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GenSight Biologics competition to find correlations between indicators driving GenSight Biologics's intrinsic value. More Info.GenSight Biologics SA is one of the top stocks in return on equity category among related companies. It is one of the top stocks in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value GenSight Biologics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for GenSight Biologics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GenSight Biologics' earnings, one of the primary drivers of an investment's value.GenSight Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GenSight Biologics' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of GenSight Biologics could also be used in its relative valuation, which is a method of valuing GenSight Biologics by comparing valuation metrics of similar companies.GenSight Biologics is currently under evaluation in operating margin category among related companies.
GenSight Fundamentals
| Return On Equity | -1.72 | |||
| Return On Asset | -0.39 | |||
| Operating Margin | (6.59) % | |||
| Current Valuation | 131.61 M | |||
| Shares Outstanding | 46.16 M | |||
| Shares Owned By Insiders | 12.75 % | |||
| Shares Owned By Institutions | 35.65 % | |||
| Price To Book | 43.18 X | |||
| Price To Sales | 34.69 X | |||
| Revenue | 5.28 M | |||
| Gross Profit | 7.71 M | |||
| EBITDA | (25.52 M) | |||
| Net Income | (28.62 M) | |||
| Cash And Equivalents | 24.15 M | |||
| Cash Per Share | 0.52 X | |||
| Total Debt | 5.64 M | |||
| Debt To Equity | 5.02 % | |||
| Current Ratio | 1.88 X | |||
| Book Value Per Share | 0.07 X | |||
| Cash Flow From Operations | (17.14 M) | |||
| Earnings Per Share | (0.67) X | |||
| Number Of Employees | 44 | |||
| Beta | 2.16 | |||
| Market Capitalization | 162.24 M | |||
| Total Asset | 56.65 M | |||
| Z Score | 16.8 | |||
| Net Asset | 56.65 M |
About GenSight Biologics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GenSight Biologics SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GenSight Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GenSight Biologics SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. GenSight Biologics S.A. was incorporated in 2012 and is headquartered in Paris, France. Gensight Biologics is traded on OTC Exchange in the United States.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards GenSight Biologics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, GenSight Biologics' short interest history, or implied volatility extrapolated from GenSight Biologics options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GenSight Biologics SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for GenSight Pink Sheet analysis
When running GenSight Biologics' price analysis, check to measure GenSight Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GenSight Biologics is operating at the current time. Most of GenSight Biologics' value examination focuses on studying past and present price action to predict the probability of GenSight Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GenSight Biologics' price. Additionally, you may evaluate how the addition of GenSight Biologics to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |